BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)

Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...

July 30, 2025 | Report

Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals

Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...

July 28, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Clearwater Partners with Google Cloud to Supercharge Healthcare Cybersecurity with Real-Time Threat Intelligence

Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the healthcare industry, today announced a collaboration with Goog...

July 25, 2025 | News

iMedX Gains Health NZ Endorsement for AI Scribe Trial Across Public Health Services

iMedX is proud to announce its formal endorsement by Health New Zealand | Te Whatu Ora as one of only two Ambient AI Scribe tools approved for trialling wi...

July 24, 2025 | News

Global Call for Self-Care Integration as World Faces NCD Crisis

On International Self-Care Day, and as world leaders prepare for a landmark United Nations General Assembly meeting on non-communicable diseases (NCDs) thi...

July 24, 2025 | News

Precision Medicine – Are We Ready for It?

Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...

July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India

Community Health Systems to Sell Ambulatory Lab Services to Labcorp for $195 Million in Multi-State Deal

Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a defi...

July 23, 2025 | News

OMRON, bolttech and QBE Launch Premium Care Plan in Singapore to Empower Proactive Heart Health

Global insurtech bolttech and OMRON Healthcare Singapore, a global leader in innovative medical equipment for health monitoring and the...

July 22, 2025 | News

Smart Implants and the Future of Musculoskeletal Injury Treatment

While these methods are structurally effective, they cannot adapt to each patient's recovery process or provide insight into the progression of healing. Th...

July 21, 2025 | News

How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress

While innovation drives progress, the absence of consistent ethical safeguards in psychiatry can distort research outcomes and undermine clinical trials. S...

July 21, 2025 | News

South Korea Approves Clinical Trial of DeepQure’s HyperQure™ System for Atrial Fibrillation

DeepQure announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the c...

July 21, 2025 | News

Fangzhou and Novo Nordisk Forge Strategic Alliance to Revolutionise Chronic Disease Management with AI

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, ...

July 21, 2025 | News

Stay Connected